GENES.biospecimen_aliquot|bcr_aliquot_barcode	tcga-04-1348-01a-01r-1565-13
GENES.biospecimen_aliquot|bcr_aliquot_uuid	1465139e-d1b2-4026-a532-08513fe0ad4d
GENES.biospecimen_aliquot|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_aliquot|bcr_sample_barcode	tcga-04-1348-01a
GENES.biospecimen_aliquot|biospecimen_barcode_bottom	1049928657
GENES.biospecimen_aliquot|center_id	13
GENES.biospecimen_aliquot|concentration	0.15
GENES.biospecimen_aliquot|date_of_shipment	2011-03-16
GENES.biospecimen_aliquot|is_derived_from_ffpe	no
GENES.biospecimen_aliquot|plate_column	2
GENES.biospecimen_aliquot|plate_id	1565
GENES.biospecimen_aliquot|plate_row	e
GENES.biospecimen_aliquot|quantity	3.00
GENES.biospecimen_aliquot|source_center	22
GENES.biospecimen_aliquot|volume	20.00
GENES.biospecimen_analyte|a260_a280_ratio	1.80
GENES.biospecimen_analyte|analyte_type	rna
GENES.biospecimen_analyte|analyte_type_id	r
GENES.biospecimen_analyte|bcr_analyte_barcode	tcga-04-1348-01a-01r
GENES.biospecimen_analyte|bcr_analyte_uuid	3bd7e2f2-2350-44bf-bdd5-71d20902bf10
GENES.biospecimen_analyte|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_analyte|bcr_sample_barcode	tcga-04-1348-01a
GENES.biospecimen_analyte|concentration	0.15
GENES.biospecimen_analyte|gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
GENES.biospecimen_analyte|is_derived_from_ffpe	no
GENES.biospecimen_analyte|ratio_28s_18s	1.20
GENES.biospecimen_analyte|rinvalue	8.40
GENES.biospecimen_analyte|spectrophotometer_method	uv spec
GENES.biospecimen_normal_control|bcr_patient_barcode	tcga-04-1348
GENES.biospecimen_normal_control|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_normal_control|normal_tissue_anatomic_site	other
GENES.biospecimen_portion|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_portion|bcr_portion_barcode	tcga-04-1348-01a-01
GENES.biospecimen_portion|bcr_portion_uuid	4ed2c866-a732-4821-93ec-a2a89f458420
GENES.biospecimen_portion|bcr_sample_barcode	tcga-04-1348-01a
GENES.biospecimen_portion|date_of_creation	2008-12-19
GENES.biospecimen_portion|is_ffpe	no
GENES.biospecimen_portion|portion_number	01
GENES.biospecimen_portion|weight	105.00
GENES.biospecimen_protocol|bcr_analyte_barcode	tcga-04-1348-01a-01r
GENES.biospecimen_protocol|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_protocol|bcr_sample_barcode	tcga-04-1348-01a
GENES.biospecimen_protocol|experimental_protocol_type	allprep rna extraction
GENES.biospecimen_sample|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_sample|bcr_sample_barcode	tcga-04-1348-01a
GENES.biospecimen_sample|bcr_sample_uuid	cdaa3a57-c3e7-4858-a048-8f75b882dde7
GENES.biospecimen_sample|intermediate_dimension	1
GENES.biospecimen_sample|is_ffpe	no
GENES.biospecimen_sample|longest_dimension	1.5
GENES.biospecimen_sample|pathology_report_file_name	tcga-04-1348.51b558ef-c11b-41a7-a7bf-15d201506006.pdf
GENES.biospecimen_sample|pathology_report_uuid	51b558ef-c11b-41a7-a7bf-15d201506006
GENES.biospecimen_sample|sample_type	primary tumor
GENES.biospecimen_sample|sample_type_id	01
GENES.biospecimen_sample|shortest_dimension	0.4
GENES.biospecimen_sample|vial_number	a
GENES.biospecimen_shipment_portion|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_shipment_portion|bcr_sample_barcode	tcga-04-1348-01a
GENES.biospecimen_shipment_portion|bcr_shipment_portion_uuid	21a891e7-6da2-4d9e-a1e3-e760605d9dee
GENES.biospecimen_shipment_portion|center_id	20
GENES.biospecimen_shipment_portion|is_ffpe	no
GENES.biospecimen_shipment_portion|plate_id	1561
GENES.biospecimen_shipment_portion|portion_number	21
GENES.biospecimen_shipment_portion|shipment_portion_bcr_aliquot_barcode	tcga-04-1348-01a-21-1561-20
GENES.biospecimen_shipment_portion|shipment_portion_day_of_shipment	14
GENES.biospecimen_shipment_portion|shipment_portion_month_of_shipment	2
GENES.biospecimen_shipment_portion|shipment_portion_year_of_shipment	2011
GENES.biospecimen_slide|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.biospecimen_slide|bcr_sample_barcode	tcga-04-1348-01a
GENES.biospecimen_slide|bcr_slide_barcode	tcga-04-1348-01a-01-bs1
GENES.biospecimen_slide|bcr_slide_uuid	06d57b7b-b6c9-49ae-86a9-9a28de14443d
GENES.biospecimen_slide|image_file_name	tcga-04-1348-01a-01-bs1.06d57b7b-b6c9-49ae-86a9-9a28de14443d.svs
GENES.biospecimen_slide|is_derived_from_ffpe	no
GENES.biospecimen_slide|percent_necrosis	8
GENES.biospecimen_slide|percent_normal_cells	0
GENES.biospecimen_slide|percent_stromal_cells	2
GENES.biospecimen_slide|percent_tumor_cells	90
GENES.biospecimen_slide|percent_tumor_nuclei	99
GENES.biospecimen_slide|section_location	bottom
GENES.biospecimen_tumor_sample|bcr_patient_barcode	tcga-04-1348
GENES.biospecimen_tumor_sample|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.clinical_drug|bcr_drug_barcode	tcga-04-1348-d23970
GENES.clinical_drug|bcr_drug_uuid	bb7bed55-0fc3-4776-9cfe-59bd4adbbe7a
GENES.clinical_drug|bcr_patient_barcode	tcga-04-1348
GENES.clinical_drug|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.clinical_drug|form_completion_date	2009-11-17
GENES.clinical_drug|pharma_adjuvant_cycles_count	7
GENES.clinical_drug|pharmaceutical_therapy_drug_name	doxil
GENES.clinical_drug|pharmaceutical_therapy_type	chemotherapy
GENES.clinical_drug|pharmaceutical_tx_ended_days_to	853
GENES.clinical_drug|pharmaceutical_tx_ongoing_indicator	no
GENES.clinical_drug|pharmaceutical_tx_started_days_to	672
GENES.clinical_drug|route_of_administration	iv
GENES.clinical_drug|therapy_regimen	recurrence
GENES.clinical_follow_up|additional_pharmaceutical_therapy	yes
GENES.clinical_follow_up|bcr_followup_barcode	tcga-04-1348-f23967
GENES.clinical_follow_up|bcr_followup_uuid	4bd91396-4007-4ff3-9673-58e37b089fe6
GENES.clinical_follow_up|bcr_patient_barcode	tcga-04-1348
GENES.clinical_follow_up|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.clinical_follow_up|death_days_to	1483
GENES.clinical_follow_up|form_completion_date	2009-3-26
GENES.clinical_follow_up|new_neoplasm_event_type	recurrence
GENES.clinical_follow_up|new_tumor_event_dx_days_to	575
GENES.clinical_follow_up|new_tumor_event_dx_evidence	molecular markers
GENES.clinical_follow_up|new_tumor_event_radiation_tx	no
GENES.clinical_follow_up|pharmaceutical_tx_adjuvant	yes
GENES.clinical_follow_up|radiation_treatment_adjuvant	no
GENES.clinical_follow_up|treatment_outcome_first_course	complete remission/response
GENES.clinical_follow_up|tumor_status	with tumor
GENES.clinical_follow_up|vital_status	dead
GENES.clinical_patient|age_at_initial_pathologic_diagnosis	44
GENES.clinical_patient|anatomic_neoplasm_subdivision	bilateral
GENES.clinical_patient|bcr_patient_barcode	tcga-04-1348
GENES.clinical_patient|bcr_patient_uuid	f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4
GENES.clinical_patient|birth_days_to	-16236
GENES.clinical_patient|clinical_stage	stage iiib
GENES.clinical_patient|days_to_initial_pathologic_diagnosis	0
GENES.clinical_patient|death_days_to	1483
GENES.clinical_patient|ethnicity	hispanic or latino
GENES.clinical_patient|form_completion_date	2009-3-26
GENES.clinical_patient|gender	female
GENES.clinical_patient|histological_type	serous cystadenocarcinoma
GENES.clinical_patient|history_neoadjuvant_treatment	no
GENES.clinical_patient|icd_10	c56.9
GENES.clinical_patient|icd_o_3_histology	8441/3
GENES.clinical_patient|icd_o_3_site	c56.9
GENES.clinical_patient|informed_consent_verified	yes
GENES.clinical_patient|initial_pathologic_dx_year	2004
GENES.clinical_patient|lymphovascular_invasion_indicator	yes
GENES.clinical_patient|method_initial_path_dx	tumor resection
GENES.clinical_patient|patient_id	1348
GENES.clinical_patient|race	white
GENES.clinical_patient|residual_disease_largest_nodule	1-10 mm
GENES.clinical_patient|tissue_source_site	04
GENES.clinical_patient|tumor_grade	g3
GENES.clinical_patient|tumor_status	with tumor
GENES.clinical_patient|tumor_tissue_site	ovary
GENES.clinical_patient|vital_status	dead
GENES.manually_curated|dataType	rnaseqv2
GENES.manually_curated|exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/ov/rnaseqv2/gene.quantification/TCGA-04-1348-01A-01R-1565-13.bed
GENES.manually_curated|exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/ov/rnaseqv2/gene.quantification/TCGA-04-1348-01A-01R-1565-13.bed.meta
GENES.manually_curated|id	tcga-04-1348-01a-01r-1565-13
GENES.manually_curated|md5sum	e21ba47e99a90a861c8f8cc76b661f57
GENES.manually_curated|rna_seq_data_unit	rsem
GENES.manually_curated|rna_seq_exp_type	gene_quantification
GENES.manually_curated|seqPlatform	illumina_hiseq_2000
GENES.manually_curated|tissue_status	tumoral
GENES.manually_curated|tumor_description	ovarian serous cystadenocarcinoma
GENES.manually_curated|tumor_tag	ov
PATIENTS.biospecimen_aliquot|bcr_aliquot_barcode	tcga-61-1740-01a-01w-0639-09
PATIENTS.biospecimen_aliquot|bcr_aliquot_uuid	0ad81b61-20fc-40d7-b0ad-6ea6bf305d82
PATIENTS.biospecimen_aliquot|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_aliquot|bcr_sample_barcode	tcga-61-1740-01a
PATIENTS.biospecimen_aliquot|center_id	09
PATIENTS.biospecimen_aliquot|concentration	0.50
PATIENTS.biospecimen_aliquot|date_of_shipment	2009-09-23
PATIENTS.biospecimen_aliquot|is_derived_from_ffpe	no
PATIENTS.biospecimen_aliquot|plate_column	3
PATIENTS.biospecimen_aliquot|plate_id	0639
PATIENTS.biospecimen_aliquot|plate_row	e
PATIENTS.biospecimen_aliquot|quantity	30.00
PATIENTS.biospecimen_aliquot|source_center	22
PATIENTS.biospecimen_aliquot|volume	60.00
PATIENTS.biospecimen_analyte|analyte_type	repli-g (qiagen) dna
PATIENTS.biospecimen_analyte|analyte_type_id	w
PATIENTS.biospecimen_analyte|bcr_analyte_barcode	tcga-61-1740-01a-01w
PATIENTS.biospecimen_analyte|bcr_analyte_uuid	fdab501e-c417-4c96-9d50-4be584fccf93
PATIENTS.biospecimen_analyte|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_analyte|bcr_sample_barcode	tcga-61-1740-01a
PATIENTS.biospecimen_analyte|concentration	0.50
PATIENTS.biospecimen_analyte|gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
PATIENTS.biospecimen_analyte|is_derived_from_ffpe	no
PATIENTS.biospecimen_analyte|normal_tumor_genotype_match	yes
PATIENTS.biospecimen_analyte|pcr_amplification_successful	no
PATIENTS.biospecimen_analyte|spectrophotometer_method	uv spec
PATIENTS.biospecimen_normal_control|bcr_patient_barcode	tcga-61-1740
PATIENTS.biospecimen_normal_control|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_portion|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_portion|bcr_portion_barcode	tcga-61-1740-01a-01
PATIENTS.biospecimen_portion|bcr_portion_uuid	9c36986a-d488-434b-a9f3-5fb27b02791c
PATIENTS.biospecimen_portion|bcr_sample_barcode	tcga-61-1740-01a
PATIENTS.biospecimen_portion|date_of_creation	2009-05-17
PATIENTS.biospecimen_portion|is_ffpe	no
PATIENTS.biospecimen_portion|portion_number	01
PATIENTS.biospecimen_portion|weight	112.00
PATIENTS.biospecimen_protocol|bcr_analyte_barcode	tcga-61-1740-01a-01w
PATIENTS.biospecimen_protocol|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_protocol|bcr_sample_barcode	tcga-61-1740-01a
PATIENTS.biospecimen_protocol|experimental_protocol_type	repli-g
PATIENTS.biospecimen_sample|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_sample|bcr_sample_barcode	tcga-61-1740-01a
PATIENTS.biospecimen_sample|bcr_sample_uuid	ac9c5b5e-8e14-4a76-a68d-78a8349c40f7
PATIENTS.biospecimen_sample|intermediate_dimension	0.4
PATIENTS.biospecimen_sample|is_ffpe	no
PATIENTS.biospecimen_sample|longest_dimension	0.6
PATIENTS.biospecimen_sample|pathology_report_file_name	tcga-61-1740.b87690ba-0cd2-458e-938f-553cd5ab6d84.pdf
PATIENTS.biospecimen_sample|pathology_report_uuid	b87690ba-0cd2-458e-938f-553cd5ab6d84
PATIENTS.biospecimen_sample|sample_type	primary tumor
PATIENTS.biospecimen_sample|sample_type_id	01
PATIENTS.biospecimen_sample|shortest_dimension	0.3
PATIENTS.biospecimen_sample|vial_number	a
PATIENTS.biospecimen_shipment_portion|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_shipment_portion|bcr_sample_barcode	tcga-61-1740-01a
PATIENTS.biospecimen_shipment_portion|bcr_shipment_portion_uuid	3349b819-24fe-404f-a480-0e94ed56a1cd
PATIENTS.biospecimen_shipment_portion|center_id	20
PATIENTS.biospecimen_shipment_portion|is_ffpe	no
PATIENTS.biospecimen_shipment_portion|plate_id	1559
PATIENTS.biospecimen_shipment_portion|portion_number	21
PATIENTS.biospecimen_shipment_portion|shipment_portion_bcr_aliquot_barcode	tcga-61-1740-01a-21-1559-20
PATIENTS.biospecimen_shipment_portion|shipment_portion_day_of_shipment	14
PATIENTS.biospecimen_shipment_portion|shipment_portion_month_of_shipment	2
PATIENTS.biospecimen_shipment_portion|shipment_portion_year_of_shipment	2011
PATIENTS.biospecimen_slide|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.biospecimen_slide|bcr_sample_barcode	tcga-61-1740-01a
PATIENTS.biospecimen_slide|bcr_slide_barcode	tcga-61-1740-01a-01-ts1
PATIENTS.biospecimen_slide|bcr_slide_uuid	883377e3-85ad-4319-9b4e-448f3b856bcf
PATIENTS.biospecimen_slide|image_file_name	tcga-61-1740-01a-01-ts1.883377e3-85ad-4319-9b4e-448f3b856bcf.svs
PATIENTS.biospecimen_slide|is_derived_from_ffpe	no
PATIENTS.biospecimen_slide|percent_lymphocyte_infiltration	10
PATIENTS.biospecimen_slide|percent_necrosis	2
PATIENTS.biospecimen_slide|percent_normal_cells	0
PATIENTS.biospecimen_slide|percent_stromal_cells	0
PATIENTS.biospecimen_slide|percent_tumor_cells	98
PATIENTS.biospecimen_slide|percent_tumor_nuclei	85
PATIENTS.biospecimen_slide|section_location	top
PATIENTS.biospecimen_tumor_sample|bcr_patient_barcode	tcga-61-1740
PATIENTS.biospecimen_tumor_sample|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.clinical_drug|bcr_drug_barcode	tcga-61-1740-d28199
PATIENTS.clinical_drug|bcr_drug_uuid	bc6d55fe-44ed-4ff5-92ae-80281edfcb66
PATIENTS.clinical_drug|bcr_patient_barcode	tcga-61-1740
PATIENTS.clinical_drug|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.clinical_drug|form_completion_date	2009-12-4
PATIENTS.clinical_drug|pharmaceutical_therapy_drug_name	tamoxifen
PATIENTS.clinical_drug|pharmaceutical_therapy_type	hormone therapy
PATIENTS.clinical_drug|pharmaceutical_tx_dose_units	mg
PATIENTS.clinical_drug|pharmaceutical_tx_ended_days_to	74
PATIENTS.clinical_drug|pharmaceutical_tx_ongoing_indicator	no
PATIENTS.clinical_drug|pharmaceutical_tx_started_days_to	23
PATIENTS.clinical_drug|pharmaceutical_tx_total_dose_units	mg
PATIENTS.clinical_drug|therapy_regimen	adjuvant
PATIENTS.clinical_drug|total_dose	1020
PATIENTS.clinical_follow_up|bcr_followup_barcode	tcga-61-1740-f28198
PATIENTS.clinical_follow_up|bcr_followup_uuid	0e3413d9-8c58-4ac6-a310-028165e36dcd
PATIENTS.clinical_follow_up|bcr_patient_barcode	tcga-61-1740
PATIENTS.clinical_follow_up|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.clinical_follow_up|death_days_to	74
PATIENTS.clinical_follow_up|ecog_score	3
PATIENTS.clinical_follow_up|form_completion_date	2009-6-2
PATIENTS.clinical_follow_up|last_contact_days_to	74
PATIENTS.clinical_follow_up|performance_status_timing	pre-adjuvant therapy
PATIENTS.clinical_follow_up|pharmaceutical_tx_adjuvant	yes
PATIENTS.clinical_follow_up|radiation_treatment_adjuvant	no
PATIENTS.clinical_follow_up|treatment_outcome_first_course	progressive disease
PATIENTS.clinical_follow_up|tumor_status	with tumor
PATIENTS.clinical_follow_up|vital_status	dead
PATIENTS.clinical_patient|age_at_initial_pathologic_diagnosis	71
PATIENTS.clinical_patient|anatomic_neoplasm_subdivision	right
PATIENTS.clinical_patient|bcr_patient_barcode	tcga-61-1740
PATIENTS.clinical_patient|bcr_patient_uuid	005a6517-2e5a-4ea3-ab36-531522723607
PATIENTS.clinical_patient|birth_days_to	-26169
PATIENTS.clinical_patient|clinical_stage	stage iiic
PATIENTS.clinical_patient|days_to_initial_pathologic_diagnosis	0
PATIENTS.clinical_patient|death_days_to	74
PATIENTS.clinical_patient|ecog_score	3
PATIENTS.clinical_patient|ethnicity	not hispanic or latino
PATIENTS.clinical_patient|form_completion_date	2009-6-2
PATIENTS.clinical_patient|gender	female
PATIENTS.clinical_patient|histological_type	serous cystadenocarcinoma
PATIENTS.clinical_patient|history_neoadjuvant_treatment	no
PATIENTS.clinical_patient|icd_10	c56.9
PATIENTS.clinical_patient|icd_o_3_histology	8441/3
PATIENTS.clinical_patient|icd_o_3_site	c56.9
PATIENTS.clinical_patient|informed_consent_verified	yes
PATIENTS.clinical_patient|initial_pathologic_dx_year	2005
PATIENTS.clinical_patient|last_contact_days_to	74
PATIENTS.clinical_patient|lymphovascular_invasion_indicator	yes
PATIENTS.clinical_patient|method_initial_path_dx	tumor resection
PATIENTS.clinical_patient|patient_id	1740
PATIENTS.clinical_patient|performance_status_timing	pre-adjuvant therapy
PATIENTS.clinical_patient|race	white
PATIENTS.clinical_patient|residual_disease_largest_nodule	>20 mm
PATIENTS.clinical_patient|tissue_source_site	61
PATIENTS.clinical_patient|tumor_grade	g3
PATIENTS.clinical_patient|tumor_status	with tumor
PATIENTS.clinical_patient|tumor_tissue_site	ovary
PATIENTS.clinical_patient|vascular_invasion_indicator	yes
PATIENTS.clinical_patient|vital_status	dead
PATIENTS.manually_curated|center	genome.wustl.edu
PATIENTS.manually_curated|dataType	dnaseq
PATIENTS.manually_curated|exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/ov/dnaseq/TCGA-61-1740-01A-01W-0639-09.bed
PATIENTS.manually_curated|exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/ov/dnaseq/TCGA-61-1740-01A-01W-0639-09.bed.meta
PATIENTS.manually_curated|id	tcga-61-1740-01a-01w-0639-09
PATIENTS.manually_curated|md5sum	92090cc26b0d37b4dacbc6542f900caf
PATIENTS.manually_curated|ncbi_build	36
PATIENTS.manually_curated|seqPlatform	illumina_ga2
PATIENTS.manually_curated|sequence_source	capture
PATIENTS.manually_curated|sequencer	illumina gaiix
PATIENTS.manually_curated|tissue_status	tumoral
PATIENTS.manually_curated|tumor_description	ovarian serous cystadenocarcinoma
PATIENTS.manually_curated|tumor_sample_uuid	0ad81b61-20fc-40d7-b0ad-6ea6bf305d82
PATIENTS.manually_curated|tumor_tag	ov
